DT Research Unveils Next-Gen Medical Tablet

They feature antimicrobial enclosures.

Screen Shot 2024 03 05 At 9 32 08 Am
DT Research

DT Research, a designer and manufacturer of computing solutions for vertical markets, today introduced the 323MD medical tablet, built to deliver point-of-care applications across a spectrum of healthcare environments. The 323MD is a solution designed for both mobile and fixed settings.

The 323MD medical tablets integrate 13-inch sunlight-readable touchscreens and energy-efficient Intel Core processors into lightweight and durable antimicrobial mobile devices designed to provide point-of-care wherever the patient is located. The tablets run Microsoft Windows 10/11 IoT Enterprise and feature a high-brightness display that is ideal for detailed imaging, such as X-rays.

For telehealth scenarios, the detachable keyboard transitions the 323MD from a stationary device at a nurse's station to a mobile device in a patient's room, supporting diverse use cases with a single, highly adaptable device. Built-in Wi-Fi, along with options for barcode scanners, dual-frequency RFID, GNSS data capture, and front/back cameras, elevates workflow efficiency for healthcare professionals.

The 323MD medical tablets are also well-suited for the landscape of field medicine applications, such as emergency response situations and attending to injuries in the field during sports events.

With an IP65 rating and MIL-STD-810H/461G certification, these tablets exhibit durability, ensuring operational functionality across a range of temperatures. The inclusion of hot-swappable batteries provides reliable performance. With antimicrobial enclosures and certified to meet ANSI/AAMI ES60601-1 standards, the tablets are purpose-built for clean-sensitive medical environments.

The 323MD rugged tablets will be available in Q3 2024 from DT Research’s authorized resellers and partners.

More in Equipment